ASHLEY CALANNI: Open Payments
NPI 1164950184 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,492 in 93 payments from 18 companies in 2025. Trend: 2023 $714 · 2024 $960 · 2025 $2,492
Food & beverage: $2,312Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $484 |
| Regeneron Healthcare Solutions, Inc. | 10 | $211 |
| PFIZER INC. | 8 | $200 |
| ABBVIE INC. | 9 | $200 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $185 |
| UCB, Inc. | 5 | $165 |
| Incyte Corporation | 6 | $159 |
| Amgen Inc. | 3 | $156 |
| Galderma Laboratories, L.P. | 8 | $151 |
| Arcutis Biotherapeutics, Inc. | 6 | $133 |
Products named: TREMFYA, CIBINQO, Bimzelx, OPZELURA, DUPIXENT, Otezla, Zoryve, RINVOQ.
Industry payments across CA — which companies pay providers there.
